In summary, our studies showed that LBP can activate the SIRT1/AMPK pathway and ameliorate dysregulated hepatic lipid metabolism in HFD-induced NAFLD mice. The gene discussed is SIRT1; the disease is metabolic dysfunction-associated steatotic liver disease.